Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
伊沙佐米(一种在研蛋白酶体抑制剂)治疗晚期非血液系统恶性肿瘤的1期研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-015-0230-x
Smith, David C; Kalebic, Thea; Infante, Jeffrey R; Siu, Lillian L; Sullivan, Daniel; Vlahovic, Gordana; Kauh, John S; Gao, Feng; Berger, Allison J; Tirrell, Stephen; Gupta, Neeraj; Di Bacco, Alessandra; Berg, Deborah; Liu, Guohui; Lin, Jianchang; Hui, Ai-Min; Thompson, John A